Skip to main content
Earnings Labs
ResMed Inc. logo

ResMed Inc. (RMD)

NYSE·Healthcare·Medical - Devices

$222.25

+3.27%

Mkt Cap $30.60B

Analyst Ratings

Buy

7

Hold

5

Sell

0

Price Target (36 analysts)

$261.43

Range $225.00$314.00

Implied Upside

+17.6%

Consensus $261.43 vs current $222.25